Physician profile
Sanjay Bhatia
NPI 1306810973
$8,717.01
in general payments reported to CMS, 2019-2025
9 companies · $3,301 in 2025
The $3,301 reported for 2025 was more than what 76% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $847 · 2020: $1,126 · 2021: $13.76 · 2022: $2,284 · 2023: $1,146 · 2025: $3,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,559 · Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,559.16 |
| Food and Beverage | $887.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,767.23 | 2022-2025 | Visualase, Pivox Oblique Lateral Spinal System, Clydesdale Ptc Spinal System |
| Medtronic USA, INC. | $1,423.78 | 2019-2020 | |
| Arthrex, INC. | $1,051.28 | 2025 | |
| Mid-Atlantic Surgical Systems, LLC | $844.81 | 2025 | |
| Integrity Implants INC. | $318.70 | 2020 | |
| Richard Wolf Medical Instruments Corp. | $229.79 | 2019 | |
| Si-Bone, INC. | $49.24 | 2025 | |
| Ethicon US, LLC | $18.42 | 2025 | Surgicel Nu-Knit, Surgiflo Hemostatic Matrix, Evarrest |
| Aesculap, INC. | $13.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Bhatia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.